U.S. equities were mixed in Thursday’s midday trade as investors digested the impact of President Donald Trump’s reciprocal tariffs deadline kicking in.
U.S. equities were mixed in Thursday’s midday trade as investors digested the impact of President Donald Trump’s reciprocal tariffs deadline kicking in.
The SPDR S&P 500 ETF (SPY), which mirrors the S&P 500 index, was down 0.29% at the time of writing, while the Invesco QQQ Trust (QQQ), which mirrors the Nasdaq, edged up by 0.02%.
Here are the top stocks making the biggest moves in Thursday’s midday trade:
Intel Corp. (INTC)
Chipmaking giant Intel’s shares were down by 3% in Thursday’s midday trading session after President Donald Trump called for the company’s CEO, Lip-Bu Tan, to step down over links to China, calling him “highly conflicted.”
INTC stock is down 1% year-to-date.
Eli Lilly & Co. (LLY)
Eli Lilly shares plunged more than 13% in Thursday’s midday trading session, after the company announced the outcome of a late-stage trial of its daily obesity pill. Eli Lilly said over 24% patients discontinued treatment at the highest doses compared to nearly 30% with placebo in the trial.
LLY stock is down 16% year-to-date.
Fortinet Inc. (FTNT)
Fortinet shares plummeted over 25% after the company announced that it is now 40% to 50% through its 2026 firewall refresh customers. Analysts flagged this as a concern, with KeyBanc downgrading the stock and saying the second-quarter (Q2) update makes for a tough setup for Fortinet shares in 2026, according to TheFly.
FTNT stock is down 23% year-to-date.
Duolingo Inc. (DUOL)
Duolingo shares skyrocketed 27% after the company’s beat-and-raise Q2 performance. The company reported earnings per share (EPS) of $0.91 on revenue of $252 million, surpassing Wall Street estimates of $0.59 and $241 million, respectively, according to Stocktwits data.
DUOL stock is up 34% year-to-date.
Nebius Group NV (NBIS)
Nebius shares surged 20% after the company’s Q2 revenue of $105 million beat Wall Street expectations of $101 million, according to Stocktwits data. The company increased its annualized run-rate revenue (ARR) guidance to $900 million to $1.1 billion, up from a range of $750 million to $1 billion.
NBIS stock is up 138% year-to-date.
For updates and corrections, email newsroom[at]stocktwits[dot]com.<